RxDoctor Payments Data

Kevin Lauck, PA

Physician Assistant · Bloomfield, NENPI 1598713885

Payments from drug & device makers

$404in general payments, 2019–2025

Across 28 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$105
  • Bayer$55
  • Biohaven Pharmaceutical Holding Company Ltd.$45
  • Lilly USA, LLC$42
  • Novo Nordisk$31
  • Biohaven Pharmaceuticals, Inc.$24
  • plus $101 from 7 others

What the payments were for

  • Food & beverage$404100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$404 in reported general payments places this provider in the 55th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$215,121
Medicare patients
330
Services billed
13,834

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban315$198,028
Tresiba Flextouch U-200Insulin Degludec52$55,893
MounjaroTirzepatide46$47,488
OzempicSemaglutide41$37,501
Trelegy ElliptaFluticasone/Umeclidin/Vilanter26$15,832
TrulicityDulaglutide14$15,727
Stiolto RespimatTiotropium Br/Olodaterol Hcl15$11,317
FarxigaDapagliflozin Propanediol16$9,788
Metoprolol Succinate282$7,118
XareltoRivaroxaban12$6,397
Xigduo XrDapaglifloz Propaned/Metformin11$6,003
Levothyroxine Sodium369$5,682
Losartan Potassium350$5,210
JardianceEmpagliflozin11$5,141
Novolog FlexpenInsulin Aspart17$5,093

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$13$198,028315 claims
Lilly USA, LLCMounjaro, Trulicity$42$63,21460 claims
Novo NordiskOzempic$31$37,50141 claims
AstraZenecaFarxiga, Symbicort$13$13,09930 claims
Johnson & JohnsonXarelto$18$6,39712 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Bloomfield

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →